Ghost Tree Capital as of Sept. 30, 2020
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 46 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 14.5 | $50M | 451k | 111.43 | |
| Trillium Therapeutics Com New | 8.0 | $28M | 2.0M | 14.21 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 5.8 | $20M | 130k | 154.32 | |
| Mersana Therapeutics (MRSN) | 5.7 | $20M | 1.1M | 18.62 | |
| Iovance Biotherapeutics (IOVA) | 5.5 | $19M | 575k | 32.92 | |
| Immunovant (IMVT) | 5.3 | $19M | 525k | 35.19 | |
| Constellation Pharmceticls I | 4.2 | $15M | 725k | 20.26 | |
| Adverum Biotechnologies | 3.5 | $12M | 1.2M | 10.30 | |
| Mirati Therapeutics | 2.9 | $10M | 60k | 166.05 | |
| Aldeyra Therapeutics (ALDX) | 2.7 | $9.3M | 1.3M | 7.41 | |
| Rocket Pharmaceuticals (RCKT) | 2.6 | $9.1M | 400k | 22.86 | |
| Sarepta Therapeutics (SRPT) | 2.6 | $9.1M | 65k | 140.43 | |
| Amicus Therapeutics (FOLD) | 2.4 | $8.5M | 600k | 14.12 | |
| Aurinia Pharmaceuticals (AUPH) | 2.3 | $8.1M | 550k | 14.73 | |
| Fate Therapeutics (FATE) | 2.3 | $8.0M | 200k | 39.97 | |
| Surface Oncology | 2.0 | $6.9M | 1.0M | 6.90 | |
| Kura Oncology (KURA) | 2.0 | $6.9M | 225k | 30.64 | |
| BioCryst Pharmaceuticals (BCRX) | 1.9 | $6.7M | 2.0M | 3.43 | |
| Syndax Pharmaceuticals (SNDX) | 1.8 | $6.3M | 425k | 14.76 | |
| Agios Pharmaceuticals (AGIO) | 1.8 | $6.1M | 175k | 35.00 | |
| Iveric Bio | 1.6 | $5.6M | 1.0M | 5.64 | |
| Tg Therapeutics (TGTX) | 1.5 | $5.4M | 200k | 26.76 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.5 | $5.0M | 806k | 6.24 | |
| Immunic (IMUX) | 1.4 | $4.9M | 265k | 18.57 | |
| Arvinas Ord (ARVN) | 1.4 | $4.7M | 200k | 23.61 | |
| Kalvista Pharmaceuticals (KALV) | 1.3 | $4.4M | 350k | 12.59 | |
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 1.2 | $4.2M | 825k | 5.04 | |
| Rapt Therapeutics (RAPT) | 1.1 | $3.7M | 115k | 32.20 | |
| Wave Life Sciences SHS (WVE) | 1.0 | $3.6M | 425k | 8.49 | |
| Xenon Pharmaceuticals (XENE) | 1.0 | $3.6M | 325k | 11.07 | |
| Nextcure (NXTC) | 1.0 | $3.5M | 400k | 8.80 | |
| Myovant Sciences | 1.0 | $3.5M | 250k | 14.05 | |
| Reata Pharmaceuticals Cl A | 0.8 | $2.9M | 30k | 97.43 | |
| Altimmune Com New (ALT) | 0.8 | $2.6M | 200k | 13.20 | |
| Regenxbio Inc equity us cm (RGNX) | 0.6 | $2.1M | 75k | 27.52 | |
| Millendo Therapeutics | 0.4 | $1.5M | 925k | 1.63 | |
| Homology Medicines | 0.4 | $1.4M | 135k | 10.70 | |
| Imv | 0.4 | $1.4M | 325k | 4.44 | |
| Biogen Idec (BIIB) | 0.3 | $1.2M | 4.2k | 283.57 | |
| Graybug Vision Com Shs | 0.3 | $953k | 75k | 12.71 | |
| Satsuma Pharmaceuticals Ord | 0.2 | $778k | 200k | 3.89 | |
| Moderna (MRNA) | 0.2 | $708k | 10k | 70.80 | |
| Akebia Therapeutics (AKBA) | 0.2 | $628k | 250k | 2.51 | |
| Amarin Corp Spons Adr New (AMRN) | 0.1 | $421k | 100k | 4.21 | |
| Bristol-myers Squibb Right 99/99/9999 | 0.1 | $281k | 125k | 2.25 | |
| Chemocentryx | 0.1 | $247k | 4.5k | 54.89 |
